The United States, Canada, and Mexico convened in Ottawa last week to coordinate their fight against fentanyl trafficking and drug-related violence.
The January 27-28 summit marked the ninth annual North American Drug Dialogue (NADD).
Policy makers, law enforcement chiefs, and public health experts from all three nations gathered to tackle evolving threats. They assessed progress on five key priorities: trafficking methods, synthetic drugs, demand reduction, illicit finances, and weapons smuggling.
The countries unveiled an ambitious three-year strategy built on three pillars. First, securing global supply chains against drug trafficking, and second, strengthening drug policy implementation and law enforcement. Third, reducing overdose deaths while increasing long-term recovery options.
Specific measures include enhanced border and postal security, disrupting firearms networks, closing financial loopholes, and deploying wastewater testing to detect drugs early.
A significant development emerged regarding China’s role in the crisis. Canada, Mexico, and the United States discussed what they called “the historic commitment President Trump secured from China in relation to the control of precursor chemical exports to North America.”
The three nations agreed to use the NADD framework to monitor China’s compliance. They aim to track improvements in closing supply chain gaps that enable fentanyl production.
The North American Drug Dialogue launched in July 2016 as a platform for transparency and coordination. Through data sharing and best practices, the initiative aims to deliver lasting solutions to the continent’s drug crisis.
